about
Comparison of human RNase 3 and RNase 7 bactericidal action at the Gram-negative and Gram-positive bacterial cell wallComparison of the membrane interaction mechanism of two antimicrobial RNases: RNase 3/ECP and RNase 7Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragmentEosinophil cationic protein high-affinity binding to bacteria-wall lipopolysaccharides and peptidoglycansExploring new biological functions of amyloids: bacteria cell agglutination mediated by host protein aggregationTwo human host defense ribonucleases against mycobacteria, the eosinophil cationic protein (RNase 3) and RNase 7Towards the rational design of antimicrobial proteins: single point mutations can switch on bactericidal and agglutinating activities on the RNase A superfamily lineage.A theoretical approach to spot active regions in antimicrobial proteins.Connecting peptide physicochemical and antimicrobial properties by a rational prediction model.The "CPC clip motif": a conserved structural signature for heparin-binding proteins.Insights into the Antimicrobial Mechanism of Action of Human RNase6: Structural Determinants for Bacterial Cell Agglutination and Membrane Permeation.A Novel RNase 3/ECP Peptide for Pseudomonas aeruginosa Biofilm Eradication That Combines Antimicrobial, Lipopolysaccharide Binding, and Cell-Agglutinating Activities.Lipopolysaccharide neutralization by antimicrobial peptides: a gambit in the innate host defense strategy.Antimicrobial peptide action on parasites.Structural determinants of the eosinophil cationic protein antimicrobial activity.Evolutionary selection for protein aggregation.Structural basis for endotoxin neutralization by the eosinophil cationic protein.Discovering new in silico tools for antimicrobial peptide prediction.Antimicrobial action and cell agglutination by the eosinophil cationic protein are modulated by the cell wall lipopolysaccharide structure.Eosinophil cationic protein aggregation: identification of an N-terminus amyloid prone region.Mapping the eosinophil cationic protein antimicrobial activity by chemical and enzymatic cleavage.Refining the eosinophil cationic protein antibacterial pharmacophore by rational structure minimization.AMPA: an automated web server for prediction of protein antimicrobial regions.Structural similarities in the CPC clip motif explain peptide-binding promiscuity between glycosaminoglycans and lipopolysaccharides.Ribonucleases as a host-defence family: evidence of evolutionarily conserved antimicrobial activity at the N-terminus.Positional scanning library applied to the human eosinophil cationic protein/RNase3 N-terminus reveals novel and potent anti-biofilm peptides.The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?Topography studies on the membrane interaction mechanism of the eosinophil cationic protein.Cells alter their tRNA abundance to selectively regulate protein synthesis during stress conditionsThe fitness cost and benefit of phase-separated protein depositsEosinophil cationic protein (ECP) can bind heparin and other glycosaminoglycans through its RNase active siteInsight into the Antifungal Mechanism of Action of Human RNase N-terminus Derived PeptidesA Coordinated Response at The Transcriptome and Interactome Level is Required to Ensure Uropathogenic Escherichia coli Survival during Bacteremia
P50
Q24300909-DDF5EC37-7F1B-4892-9250-FA0DAB511DCDQ28241249-48C6267A-E9A0-4F04-808C-70C6CD676BA6Q28245370-BD86B02B-561B-4586-B354-48B7299FEF62Q28269724-67281334-75E1-489D-9374-66DA9308DDDFQ28484823-6291F7BF-4B67-4F1F-A5ED-663FCD79439EQ28675382-E72FB6B6-24BD-427D-A41E-C98B078AA332Q30032654-1124DC3E-36E8-4993-BACF-464A277EC33BQ30882053-4EE63824-26AB-4AB4-8886-0F1F3C866A1AQ33828728-2D6856D4-13ED-4402-8780-E18707472DCFQ34374614-DA976738-6364-43AE-A995-9134862DE451Q36847194-5883D89C-3ED7-4389-9D83-7DEA413D7ACDQ37287708-9754F2F8-3298-4FAA-8188-8BF13D24CB41Q37996318-F95E6ED0-FD72-4181-B28A-FF208A0023A6Q38015949-3829D1A4-AAB7-4450-9DC1-E2566E102D1BQ38040265-A4205DCA-6510-4AE9-95BF-71CFAA8F0165Q38044424-140F024D-AD20-4D56-915E-5725CDE1A5A5Q38735177-DE4E237A-FC3C-4DE6-8965-F66F5F7182DDQ39608139-C574E2F7-8578-43FC-9125-93E150558767Q42110695-DE2B3346-B6A4-4AD3-99DF-D8486D750BDBQ42944364-85284C8B-3618-490C-B88A-C30B27B197FFQ45768387-8452DED8-CC97-4963-A0E7-8CDC8073E061Q45925540-BDF3AE46-1D76-4A7D-872A-B1C15A769349Q45998428-110EBDF1-570F-41D9-B5A1-1B743331E889Q47349870-BB7798CB-3254-4A97-87D2-051D3694C5FCQ47739339-012A323C-4F25-489A-961D-31716648F9D5Q53681978-3292B1E6-643B-4248-8FA6-D851D23F0F82Q54352699-0F22A587-EE3D-470E-BF71-979D54D46DFCQ54448487-2EAB1F50-2080-440F-9CE1-670DC00A9EF1Q58434629-BC4FA741-D6F5-437C-B9F6-527F735700FCQ64067570-2786DE2B-E2BF-4B3E-9BBC-0268C41E5F96Q83157806-85D19ACA-A226-4B93-9A70-9928C4B3A3E8Q90193059-21895528-88A6-413C-B198-5AB60CB61ABBQ92875126-387C0B0C-84D9-4CE7-AF85-0DD3C0C1AC56
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marc Torrent
@ast
Marc Torrent
@en
Marc Torrent
@es
Marc Torrent
@nl
Marc Torrent
@sl
type
label
Marc Torrent
@ast
Marc Torrent
@en
Marc Torrent
@es
Marc Torrent
@nl
Marc Torrent
@sl
prefLabel
Marc Torrent
@ast
Marc Torrent
@en
Marc Torrent
@es
Marc Torrent
@nl
Marc Torrent
@sl
P108
P1053
A-5171-2010
P106
P108
P21
P31
P3829
P3835
marc-torrent
P496
0000-0001-6567-3474